Cochrane Abstracts
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion‐dependent thalassaemia Edited (no change to conclusions)
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion‐dependent thalassaemia Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Desferrioxamine Mesylate for Managing Transfusional Iron Overload in People With Transfusion‐dependent Thalassaemia Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431374/all/Desferrioxamine_mesylate_for_managing_transfusional_iron_overload_in_people_with_transfusion���������dependent_thalassaemia_Edited__no_change_to_conclusions_. Accessed 22 March 2023.
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion‐dependent thalassaemia Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431374/all/Desferrioxamine_mesylate_for_managing_transfusional_iron_overload_in_people_with_transfusion���������dependent_thalassaemia_Edited__no_change_to_conclusions_. Accessed March 22, 2023.
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion‐dependent thalassaemia Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431374/all/Desferrioxamine_mesylate_for_managing_transfusional_iron_overload_in_people_with_transfusion���������dependent_thalassaemia_Edited__no_change_to_conclusions_
Desferrioxamine Mesylate for Managing Transfusional Iron Overload in People With Transfusion‐dependent Thalassaemia Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2023 March 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431374/all/Desferrioxamine_mesylate_for_managing_transfusional_iron_overload_in_people_with_transfusion���������dependent_thalassaemia_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion‐dependent thalassaemia Edited (no change to conclusions)
ID - 431374
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431374/all/Desferrioxamine_mesylate_for_managing_transfusional_iron_overload_in_people_with_transfusion���������dependent_thalassaemia_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
